The Staging Project is now entering the third cycle, with the goal of developing recommendations for the ninth edition of TNM. Staging lung cancer and other thoracic malignancies accurately is critical in deciding treatment regimens and ensures best standardized care for patients worldwide. New data elements such as genetic biomarkers, protein alterations and copy number alterations (CNAs) will be added to the staging project for the first time, and such additions and enhancements to the system may significantly improve the current staging system leading to more precise treatment decisions and improvement in patient survival. This resource explains the data requirements and submission process.
Staging Project Resource
International Staging Project Data Submission and Query Toolkit